• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种样本节约型多路复用 ADCP 检测法。

A Sample-Sparing Multiplexed ADCP Assay.

机构信息

The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States.

出版信息

Front Immunol. 2019 Aug 13;10:1851. doi: 10.3389/fimmu.2019.01851. eCollection 2019.

DOI:10.3389/fimmu.2019.01851
PMID:31456799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6700248/
Abstract

Antibodies serve as the primary correlate of protection following most clinically approved vaccines and are thought to confer protection in part through their ability to block (neutralize) infection. Increasingly, studies have shown that beyond their blocking activities, the ability of antibodies to leverage the innate immune response may serve a vital role in protection from infection. Specifically, antibodies can drive phagocytosis, complement activation, and cellular cytotoxicity by interacting with Fc-receptors found on all innate immune cells. Measuring the capacity of antibodies to induce these functions has become critical for the identification of correlates of protection in large-scale vaccine trials. Therefore, there is a growing need to develop robust, high throughput assays able to interrogate the functional capacity of innate immune recruiting antibodies. However, in many instances, only small sample volumes are available. Nevertheless, profiling antibody functions across many pathogen-associated antigens or across global intra-pathogen variants is in high demand, making sample sparing approaches to perform this antibody evaluation critical. Here we describe the development of an approach to interrogate the functional activity of antibodies in serum against up to 5 antigen targets simultaneously. A single bead-based cellular assay was adapted to accommodate 5 different fluorescently colored beads, allowing for the concurrent investigation of antibody responses directed against multiple antigens in a single well. The multiplexed assay was as sensitive, specific, and accurate as the single antigen assay and robustly able to assess functional differences mediated by antibodies across different samples. These findings show multiplexing allows for accurate and more efficient analysis of antibody-mediated effector profiles.

摘要

抗体是大多数经临床批准的疫苗接种后产生的主要保护相关物,被认为通过其阻断(中和)感染的能力提供部分保护。越来越多的研究表明,除了阻断作用外,抗体利用先天免疫反应的能力可能在防止感染方面发挥重要作用。具体而言,抗体可以通过与所有先天免疫细胞上发现的 Fc 受体相互作用,驱动吞噬作用、补体激活和细胞毒性。测量抗体诱导这些功能的能力对于在大规模疫苗试验中确定保护相关物变得至关重要。因此,迫切需要开发能够探究先天免疫募集抗体功能能力的强大、高通量检测方法。然而,在许多情况下,只有少量的样本可用。尽管如此,对许多病原体相关抗原或整个病原体内部变异体的抗体功能进行分析的需求很高,因此采用节省样本的方法来进行这种抗体评估至关重要。在这里,我们描述了一种方法的开发,该方法可同时检测血清中针对多达 5 个抗原靶标的抗体的功能活性。我们对单个基于珠子的细胞检测方法进行了改编,以适应 5 种不同的荧光珠,从而可以在单个孔中同时研究针对多种抗原的抗体反应。这种多重检测方法与单个抗原检测方法一样敏感、特异和准确,并且能够稳健地评估来自不同样本的抗体介导的功能差异。这些发现表明,多重检测方法可实现抗体介导的效应因子谱的准确和更高效分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/9f22b363d0c7/fimmu-10-01851-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/e39cb02fecbc/fimmu-10-01851-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/bed247e6afe0/fimmu-10-01851-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/d9b64ca745cd/fimmu-10-01851-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/7ca915625796/fimmu-10-01851-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/6017be56bf18/fimmu-10-01851-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/9f22b363d0c7/fimmu-10-01851-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/e39cb02fecbc/fimmu-10-01851-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/bed247e6afe0/fimmu-10-01851-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/d9b64ca745cd/fimmu-10-01851-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/7ca915625796/fimmu-10-01851-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/6017be56bf18/fimmu-10-01851-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b27b/6700248/9f22b363d0c7/fimmu-10-01851-g0006.jpg

相似文献

1
A Sample-Sparing Multiplexed ADCP Assay.一种样本节约型多路复用 ADCP 检测法。
Front Immunol. 2019 Aug 13;10:1851. doi: 10.3389/fimmu.2019.01851. eCollection 2019.
2
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.用于评估抗原特异性抗体效应子谱的多重Fc阵列。
J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3.
3
Determining the phagocytic activity of clinical antibody samples.测定临床抗体样本的吞噬活性。
J Vis Exp. 2011 Nov 30(57):e3588. doi: 10.3791/3588.
4
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses.抗体依赖的细胞吞噬作用在抗病毒免疫反应中的作用。
Front Immunol. 2019 Feb 28;10:332. doi: 10.3389/fimmu.2019.00332. eCollection 2019.
5
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.Fc 介导的呼吸道合胞病毒感染和疾病中的抗体效应功能。
Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019.
6
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation.一种高通量、基于珠粒的抗原特异性测定法,用于评估抗体诱导补体激活的能力。
J Immunol Methods. 2019 Oct;473:112630. doi: 10.1016/j.jim.2019.07.002. Epub 2019 Jul 10.
7
A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis.一种多功能高通量测定法,用于表征抗体介导的中性粒细胞吞噬作用。
J Immunol Methods. 2019 Aug;471:46-56. doi: 10.1016/j.jim.2019.05.006. Epub 2019 May 25.
8
Systems serology for evaluation of HIV vaccine trials.用于评估HIV疫苗试验的系统血清学
Immunol Rev. 2017 Jan;275(1):262-270. doi: 10.1111/imr.12503.
9
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.一种用于测定临床抗体样本吞噬活性的稳健、高通量检测方法。
J Immunol Methods. 2011 Mar 7;366(1-2):8-19. doi: 10.1016/j.jim.2010.12.016. Epub 2010 Dec 27.
10
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.

引用本文的文献

1
Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functions.靶向肿瘤相关抗原的工程化人B细胞具有抗原呈递和抗体介导功能。
Front Immunol. 2025 Jul 30;16:1621222. doi: 10.3389/fimmu.2025.1621222. eCollection 2025.
2
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trial.用mRNA、腺病毒或灭活新冠疫苗进行初免的成年人中UB-612异源加强针的安全性和免疫原性:一项随机、活性对照的3期试验。
EClinicalMedicine. 2025 Jul 21;86:103349. doi: 10.1016/j.eclinm.2025.103349. eCollection 2025 Aug.
3

本文引用的文献

1
A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis.一种多功能高通量测定法,用于表征抗体介导的中性粒细胞吞噬作用。
J Immunol Methods. 2019 Aug;471:46-56. doi: 10.1016/j.jim.2019.05.006. Epub 2019 May 25.
2
The Antibodiome-Mapping the Humoral Immune Response to HIV.抗体组学——描绘 HIV 的体液免疫反应
Curr HIV/AIDS Rep. 2019 Apr;16(2):169-179. doi: 10.1007/s11904-019-00432-x.
3
A novel method for determining antibody-dependent cellular phagocytosis.一种用于测定抗体依赖的细胞吞噬作用的新方法。
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates.
利用混合聚合物微粒降解速率优化多价亚单位流感疫苗的递送
J Control Release. 2025 Aug 10;384:113936. doi: 10.1016/j.jconrel.2025.113936. Epub 2025 Jun 6.
4
Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta.急性传染性单核细胞增多症会产生对α-晶状体蛋白β具有高交叉反应性的持久性功能性EBNA-1抗体。
Cell Rep. 2025 May 27;44(5):115709. doi: 10.1016/j.celrep.2025.115709. Epub 2025 May 13.
5
Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaques.克里米亚-刚果出血热病毒复制子颗粒疫苗在恒河猴中是安全的,并能引发功能性、非中和性抗核蛋白抗体和T细胞活化。
Antiviral Res. 2025 Jan;233:106045. doi: 10.1016/j.antiviral.2024.106045. Epub 2024 Dec 1.
6
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights.探索SARS-CoV-2疫苗效力中B细胞介导的免疫和抗体监测领域:工具、策略及临床试验见解
Vaccines (Basel). 2024 Sep 24;12(10):1089. doi: 10.3390/vaccines12101089.
7
Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques.猕猴中针对新冠病毒奥密克戎毒株的组织特异性抗体保护相关性
iScience. 2024 Jun 4;27(9):110174. doi: 10.1016/j.isci.2024.110174. eCollection 2024 Sep 20.
8
Antibody-mediated control mechanisms of viral infections.病毒感染的抗体介导控制机制。
Immunol Rev. 2024 Nov;328(1):205-220. doi: 10.1111/imr.13383. Epub 2024 Aug 20.
9
Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice.克里米亚-刚果出血热病毒核蛋白与GP38亚单位疫苗组合可预防小鼠发病。
NPJ Vaccines. 2024 Aug 14;9(1):148. doi: 10.1038/s41541-024-00931-y.
10
Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function.预测志贺氏菌病感染保护的免疫反应决定因素:抗体谱和功能的系统分析。
Lancet Microbe. 2024 Oct;5(10):100889. doi: 10.1016/S2666-5247(24)00112-5. Epub 2024 Aug 5.
J Immunol Methods. 2019 May;468:55-60. doi: 10.1016/j.jim.2019.03.001. Epub 2019 Mar 14.
4
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.嵌合纳米颗粒展示多样化的流感病毒血凝素可引发广泛的 B 细胞反应。
Nat Immunol. 2019 Mar;20(3):362-372. doi: 10.1038/s41590-018-0305-x. Epub 2019 Feb 11.
5
Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses.多地区设计的流感抗体提高了对季节性病毒的亲和力和广谱性。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1597-1602. doi: 10.1073/pnas.1806004116. Epub 2019 Jan 14.
6
Antibody-mediated protection against Ebola virus.抗体介导的埃博拉病毒防护。
Nat Immunol. 2018 Nov;19(11):1169-1178. doi: 10.1038/s41590-018-0233-9. Epub 2018 Oct 17.
7
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV.免疫途径决定了疫苗介导的 SIV 保护的多种机制。
Nat Med. 2018 Oct;24(10):1590-1598. doi: 10.1038/s41591-018-0161-0. Epub 2018 Sep 3.
8
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.针对埃博拉病毒 GP 的单克隆抗体的系统分析定义了有助于保护的特征。
Cell. 2018 Aug 9;174(4):938-952.e13. doi: 10.1016/j.cell.2018.07.033.
9
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.Fc 功能在治疗性单克隆抗体预防埃博拉病毒中的作用。
Cell Host Microbe. 2018 Aug 8;24(2):221-233.e5. doi: 10.1016/j.chom.2018.07.009.
10
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).在一项多中心、随机、双盲、安慰剂对照的 1/2a 期临床试验(APPROACH)和恒河猴(NHP 13-19)中评估马赛克 HIV-1 疫苗。
Lancet. 2018 Jul 21;392(10143):232-243. doi: 10.1016/S0140-6736(18)31364-3. Epub 2018 Jul 6.